Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Emirate of Abu Dhabi $5 billion notes offering
Davis Polk advised the joint lead managers in connection with a Rule 144A/Regulation S offering by the Emirate of Abu Dhabi of $2 billion aggregate principal amount of 0.750% notes due 2023…
Royalty Pharma $6 billion senior notes offering
Davis Polk advised Royalty Pharma plc in connection with its Rule 144A/Regulation S offering of $1 billion aggregate principal amount of its 0.75% senior notes due 2023, $1 billion…
SEB $2 billion notes offering
Davis Polk advised the joint book-running managers on the Rule 144A/Regulation S offering by SEB of $1 billion aggregate principal amount of 0.550% notes due 2023, $600 million…
Cellnex Telecom €4 billion equity offering
Davis Polk advised Cellnex Telecom, S.A. as to U.S. law in connection with its offering of 101,382,140 new ordinary shares pursuant to a public rights offering in Spain and private…
CureVac $245.3 million IPO
Davis Polk advised CureVac N.V. on its $245.3 million initial public offering of 15,333,332 of its common shares, which includes 1,999,999 common shares from the full exercise of the…
Linde $1 billion notes offering
Davis Polk advised the underwriters on the registered offering of $700 million aggregate principal amount of 1.100% notes due 2030 and $300 million aggregate principal amount of 2.000%…
Back to top